Cargando…

Function of interleukin-17 and −35 in the blood of patients with hepatitis B-related liver cirrhosis

Intrahepatic T helper (Th)17 cytokine and serum interleukin (IL)-17 levels in patients with hepatitis B are positively correlated with the progression of liver cirrhosis (LC). IL-35 can significantly inhibit the differentiation of Th17 cells and the synthesis of IL-17. The present study aimed to inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	SHI, MIN, WEI, JUE, DONG, JINBIN, MENG, WENYING, MA, JIALI, WANG, TING, WANG, NA, WANG, YUGANG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237084/ https://www.ncbi.nlm.nih.gov/pubmed/25323532 http://dx.doi.org/10.3892/mmr.2014.2681

Ejemplares similares

Treg/Th17 imbalance and its clinical significance in patients with hepatitis B-associated liver cirrhosis
por: Lan, Yong-Ting, et al.
Publicado: (2019)

Interleukin 35 regulates interleukin 17 expression and T helper 17 in patients with proliferative diabetic retinopathy
por: Yan, Ai, et al.
Publicado: (2022)

FOXD1‐AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway
por: Wu, Qiong, et al.
Publicado: (2020)

The role of T helper 17 cells in the pathogenesis of hepatitis B virus-related liver cirrhosis
por: Bao, Suxia, et al.
Publicado: (2017)

Interleukin-10 Genotype Correlated to Deficiency Syndrome in Hepatitis B Cirrhosis
por: Li, Qing-Ya, et al.
Publicado: (2012)

Interleukin-17 Contributes to the Pathogenesis of Autoimmune Hepatitis through Inducing Hepatic Interleukin-6 Expression
por: Zhao, Li, et al.
Publicado: (2011)

Hepatic inflammasome activation as origin of Interleukin-1α and Interleukin-1β in liver cirrhosis
por: Praktiknjo, Michael, et al.
Publicado: (2021)

Changes of Th17/Treg ratio in the transition of chronic hepatitis B to liver cirrhosis and correlations with liver function and inflammation
por: Mou, Haijuan, et al.
Publicado: (2019)

Interleukin-35 Is Involved in Angiogenesis/Bone Remodeling Coupling Through T Helper 17/Interleukin-17 Axis
por: Zhang, Hui, et al.
Publicado: (2021)

Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses
por: Meng, Ping, et al.
Publicado: (2016)

The association between vitamin D-related gene polymorphisms and hepatitis B virus-related liver cirrhosis
por: Wu, Jiali, et al.
Publicado: (2020)

Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection
por: Shao, Xue, et al.
Publicado: (2017)

Effects of hepatic blood inflow on liver ultrastructure and regeneration after extensive liver resection in rats with cirrhosis
por: Jin, Wang-Xun, et al.
Publicado: (2018)

Expression of Interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection
por: Du, Wen-Jun, et al.
Publicado: (2013)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Hepatitis B Related Liver Cirrhosis in Oman
por: Al-Naamani, Khalid, et al.
Publicado: (2022)

Long non‐coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1
por: Wu, Qiong, et al.
Publicado: (2018)

Hepatic adenomatosis in liver cirrhosis
por: Gordic, Sonja, et al.
Publicado: (2017)

Regulation of Id1 expression by epigallocatechin-3-gallate and its effect on the proliferation and apoptosis of poorly differentiated AGS gastric cancer cells
por: MA, JUN, et al.
Publicado: ( 201)

Interleukin-35 Level Is Reduced in Patients with Chronic Hepatitis B Virus Infection
por: Cheng, Sheng-Tao, et al.
Publicado: (2018)

Safety and Efficacy of Hepatitis B Vaccination in Cirrhosis of Liver
por: Roni, D. Ajith, et al.
Publicado: (2013)

Interleukin-35 on B cell and T cell induction and regulation
por: Huang, Ai, et al.
Publicado: (2017)

Liver function and energy metabolism in hepatocellular carcinoma developed in patients with hepatitis B-related cirrhosis
por: Ren, Meixin, et al.
Publicado: (2019)

Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection
por: He, Ziming, et al.
Publicado: (2020)

On the Core Prescriptions and Their Mechanisms of Traditional Chinese Medicine in Hepatitis B, Liver Cirrhosis, and Liver Cancer Treatment
por: Wang, Zhendong, et al.
Publicado: (2022)

Prognostic Value of Serum Exosomal AHCY Expression in Hepatitis B-Induced Liver Cirrhosis
por: Tong, Ling, et al.
Publicado: (2021)

Correction: Ping Meng, et al. Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses. Int. J. Mol. Sci. 2016, 17, 1070
por: Meng, Ping, et al.
Publicado: (2016)

Increased Interleukin-17 in Peripheral Blood and Cerebrospinal Fluid of Neurosyphilis Patients
por: Wang, Cuini, et al.
Publicado: (2014)

Interleukin-35 mitigates the function of murine transplanted islet cells via regulation of Treg/Th17 ratio
por: Zongyi, Yin, et al.
Publicado: (2017)

Liver cirrhosis: a risk factor for gallstone disease in chronic hepatitis C patients in China
por: Li, Xu, et al.
Publicado: (2017)

IL-35: A Novel Immunomodulator in Hepatitis B Virus-Related Liver Diseases
por: Li, Xuefen, et al.
Publicado: (2021)

Dyslipidemia and impaired liver function biomarkers in patients with hepatitis B liver cirrhosis
por: Shoaib, Naila, et al.
Publicado: (2023)

Liver Sinusoidal Endothelial Cells Contribute to Hepatic Antigen-Presenting Cell Function and Th17 Expansion in Cirrhosis
por: Caparrós, Esther, et al.
Publicado: (2020)

Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis
por: Ma, Li-Na, et al.
Publicado: (2017)

Factors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosis
por: Chen, Sheng-Sen, et al.
Publicado: (2016)

Hepatic Encephalopathy Is Not Always due to Liver Cirrhosis
por: Ecker, Miriam Eva, et al.
Publicado: (2022)

Interleukin-35 Suppresses Interleukin-9-Secreting CD4(+) T Cell Activity in Patients With Hepatitis B-Related Hepatocellular Carcinoma
por: Zhang, Qian, et al.
Publicado: (2021)

Overt Acute Hepatitis B Deteriorates in Females: Destructive Immunity With an Exaggerated Interleukin-17 Pathway
por: Chang, Ming-Ling, et al.
Publicado: (2021)

Effect of interleukin (IL)-35 on IL-17 expression and production by human CD4(+) T cells
por: Okada, Kosuke, et al.
Publicado: (2017)

Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection
por: Yang, Lanlan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8tlnm3mvca6qig0d04d946bfii